Sherrie Eaves
Psychiatric/Mental Health · Butte, MTNPI 1518711951
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $470 of the $581 with a category attached, or 80.8%. 7 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 41.0% of the total.
Across 24 payments — averaging $24.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$238
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$95
- Vanda Pharmaceuticals Inc.$86
- Neurocrine Biosciences, Inc.$72
- Johnson & Johnson$53
- Lundbeck LLC$22
- plus $15 from 1 others
What the payments were for
- Food & beverage$47081%
- Education$11119%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $238 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $95 |
| Vanda Pharmaceuticals Inc. | 4 | $86 |
| Neurocrine Biosciences, Inc. | 3 | $72 |
| Johnson & Johnson | 3 | $53 |
| Lundbeck LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
How this compares
$581 in reported general payments places this provider in the 80th percentile of 142 psychiatric/mental health providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 24 | $63,711 |
| AristadaAripiprazole Lauroxil | 11 | $25,525 |
| Lurasidone Hcl | 25 | $6,127 |
| Olanzapine | 62 | $1,035 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $1,001 |
| Haloperidol Decanoate | 18 | $922 |
| Buspirone Hcl | 45 | $797 |
| Prazosin Hcl | 41 | $701 |
| Lamotrigine | 72 | $578 |
| Propranolol Hcl | 39 | $481 |
| Bupropion XlBupropion Hcl | 16 | $393 |
| Mirtazapine | 42 | $391 |
| Doxepin Hcl | 22 | $384 |
| Benztropine Mesylate | 34 | $361 |
| Hydroxyzine Hcl | 15 | $243 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $53 | $63,71124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 142 psychiatric/mental health providers in Montana.
Other psychiatric/mental health in Butte
- Tommie PerusichButte$4K
- Elizabeth HollingsworthButte$1K
- Danielle BertramButte$1K
- Kindra ParksButte$1K
- Peggy WolsteinButte$770
- Krista BrysonButte$448
- Robin BeckerButte$353
- Tayler RydalchButte$341
- Amber DayhuffButte$292
- Heather BrownKalispell$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.